• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW ARTERIAL CATH SET: 18 GA X 8CM; CATHETER PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ARROW ARTERIAL CATH SET: 18 GA X 8CM; CATHETER PERCUTANEOUS Back to Search Results
Catalog Number SAC-00818-PBX
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Obstruction of Flow (2423)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/20/2023
Event Type  malfunction  
Manufacturer Narrative
Qn# (b)(4).
 
Event Description
It was reported that: "incident occurred on (b)(6) 2023.Within 48 hours after insertion, the catheter no longer worked properly: it was impossible to sample blood (no return of arterial blood) and the arterial pressure waveform gets flat resulting in a lack of blood pressure monitoring.Consequence: blood pressure monitored with the armband, allowing secure monitoring, but not sufficient for an intensive care department monitoring (drug therapy).We attempted to replace the catheter but with similar difficulties." it was reported the patient's condition is "stable".There was no patient injury or medical intervention needed.
 
Manufacturer Narrative
(b)(4).The customer returned one arterial catheter for analysis.Signs of use in the form of biological material were observed inside the extension lines.Visual analysis revealed that the catheter body contained two kinks.Microscopic examination confirmed the damage.No other defects or anomalies were observed.The kinks on the catheter measured 0mm and 23mm from the juncture hub.The catheter length from the juncture hub to the distal tip measured 84mm, which is within the specification limits of 83mm-86mm per the catheter product drawing.The catheter body outer diameter measured 1.24mm, which is within the specification limits of 1.24mm-1.30mm per the catheter extrusion product drawing.A lab inventory syringe filled with water was attached to the returned catheter and flushed.Biological material was observed exiting the distal tip of the catheter body.This biomaterial likely contributed to the customer report of a blocked catheter.After the biomaterial was removed, water was observed exiting the distal tip of the catheter with little to no difficulty.Performed per ifu statement, "maintain catheter patency according to institutional policies, procedures and practice guidelines".A lab inventory guide wire with a diameter of 0.025" was inserted through the distal tip of the catheter.Minor resistance was encountered at the location of the kinks; however, the guide wire was able to pass completely through the catheter.A device history record review was performed, and no relevant findings were identified.The ifu provided with the kit informs the user, "use care when removing guidewire.If resistance is encountered, remove guidewire and catheter together as a unit.Use of excessive force may damage catheter or guidewire".The ifu also states, "use care when removing guidewire.If resistance is encountered, remove guidewire and catheter together as a unit.Use of excessive force may damage catheter or guidewire".The report of a blocked catheter was confirmed through complaint investigation of the returned sample.Visual analysis revealed two kinks on the catheter body.Additionally, congealed biological material was observed exiting the catheter body during functional testing.The kinking and the biomaterial both can contribute to any blockages encountered during the procedure.Despite this, the catheter met all relevant dimensional requirements.Once the biomaterial was removed from the catheter, the catheter body appeared to flush as intended.A device history record review was performed, and no relevant findings were identified.Based on the customer report and the sample received , unintentional use error likely caused or contributed to this event.Teleflex will continue to monitor and trend for reports of this nature.
 
Event Description
It was reported that: "incident occurred on 20 february 2023.Within 48 hours after insertion, the catheter no longer worked properly: it was impossible to sample blood (no return of arterial blood) and the arterial pressure waveform gets flat resulting in a lack of blood pressure monitoring.Consequence: blood pressure monitored with the armband, allowing secure monitoring, but not sufficient for an intensive care department monitoring (drug therapy).We attempted to replace the catheter but with similar difficulties.".It was reported the patient's condition is "stable".There was no patient injury or medical intervention needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW ARTERIAL CATH SET: 18 GA X 8CM
Type of Device
CATHETER PERCUTANEOUS
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL CR, A.S.
jamska 2359/47
zdar nad sazavou 591 0 1
EZ   591 01
Manufacturer Contact
katharine tarpley
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key16582115
MDR Text Key311685533
Report Number3006425876-2023-00254
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K171146
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberSAC-00818-PBX
Device Lot Number71F22J3131
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/10/2023
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/21/2023
Initial Date FDA Received03/21/2023
Supplement Dates Manufacturer Received04/10/2023
Supplement Dates FDA Received04/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NOT REPORTED; NOT REPORTED
-
-